Elysium Healthcare Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Elysium Healthcare Limited - overview
Established
2016
Location
Borehamwood, Hertfordshire, UK
Primary Industry
Healthcare
About
Elysium Healthcare Limited is a UK-based provider of holistic, person-centered care, specializing in mental health, learning disabilities, and neurological services, delivered across various facilities including hospitals and community homes. Founded in 2016 and headquartered in Borehamwood, UK, Elysium Healthcare Limited focuses on delivering specialized care in mental health, learning disabilities, and neurological services. The company has successfully completed 2 significant deals, with its most recent being a TRADE SALE to Ramsay Health Care Limited Group on December 12, 2021, for GBP 775 million, which marked a strategic expansion into the U. K.
mental health market. The CEO is Joy Chamberlain, and the founder is Naser Fouad, who has a history of involvement in healthcare ventures. Elysium Healthcare specializes in delivering holistic, person-centered care across a range of settings, which includes hospitals, residential facilities, and community-based homes. Their core service offerings encompass divisions focused on Mental Health and Wellbeing, Learning Disabilities and Autism, Neurological care, and Children and Education.
The company employs expert clinicians and therapists who work collaboratively to create tailored care pathways aimed at addressing the diverse and complex needs of their client base, which includes individuals requiring specialist care. Established in 2016, Elysium Healthcare operates throughout the United Kingdom, catering to patients, families, and healthcare professionals seeking specialized care solutions. In the most recent fiscal year, 2023, Elysium Healthcare reported a revenue of GBP 198,463,047. 8 and an EBITDA of GBP -58,491,443, reflecting the financial outcomes of their specialized care services model that emphasizes individualized patient care.
The acquisition by Ramsay Health Care Limited Group in early 2022 is expected to enhance Elysium Healthcare's growth, expanding its footprint within the GBP 15 billion U. K. mental health market. The company plans to leverage the new funding to develop upcoming products focused on advanced therapeutic programs and expand into new geographical markets across the UK.
Elysium's strategic emphasis on aligning with Ramsay's operational framework is aimed at achieving significant growth over the next five-plus years.
Primary Industry
Healthcare
Sub Industries
Education & Training Services, Hospitals, Home Healthcare, Nursing Homes & Assisted Living, Mental Health Services
Website
www.elysiumhealthcare.co.uk/
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Elysium Healthcare Limited - timeline of key events
Elysium Healthcare Limited - financials
| Fiscal Year Ended | Mar 31, 2015 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Jun 30, 2023 | Jun 30, 2024 | Jun 30, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 2,955,785 | 2,262,248 | 13,759,000 | 53,599,000 | 61,172,000 | 74,044,000 | 84,223,000 | 97,151,000 | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | 289.6% | 14.1% | 21.0% | 13.7% | 15.3% | - | - | - | - |
| EBITDA (USD) | 517,799 | 852,388 | (355,000) | (5,389,000) | (10,574,000) | (10,720,000) | (14,273,000) | (20,587,000) | - | - | - | - |
| Operating Income (USD) | 453,552 | 832,187 | (887,000) | (7,908,000) | (13,630,000) | (14,252,000) | (18,581,000) | (25,588,000) | - | - | - | - |
| Operating Margin | 15.3% | 36.8% | (6.4%) | (14.8%) | (22.3%) | (19.2%) | (22.1%) | (26.3%) | - | - | - | - |
| % EBITDA Margin | 17.5% | 37.7% | (2.6%) | (10.1%) | (17.3%) | (14.5%) | (16.9%) | (21.2%) | - | - | - | - |
| NET Income (USD) | 408,643 | 833,735 | (397,000) | 9,121,000 | (14,584,000) | (16,024,000) | (19,191,000) | (25,941,000) | - | - | - | - |
| % Net Margin | 13.8% | 36.9% | (2.9%) | 17.0% | (23.8%) | (21.6%) | (22.8%) | (26.7%) | - | - | - | - |
Elysium Healthcare Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Elysium Healthcare Limited | - | ||||||||
| Add-on | Completed | Badby Group | - | ||||||||
| Secondary Buyout | Completed | Elysium Healthcare Limited | - |
Displaying 1 - 3 of 3
Elysium Healthcare Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.